Quoting Hon. Jill Hennessy, Vice-Chancellors Professorial Fellow at Monash University, and former Attorney-General & Minister for Health, stated on LinkedIn:
“Extraordinary breaking news from Hudson Research right here in Melbourne that a new blood test to transform ovarian cancer diagnosis is under development.
Our very own Dr Andrew Stephens identified a novel biomarker that is produced early in ovarian cancers but not in non-malignant diseases. Currently there is no early detection test for ovarian cancer and tragically only a 49 percent chance of surviving five years.
We need radical breakthroughs. And this is a pretty remarkable crossroad.
Thanks to Ovarian Cancer Research Foundation funding and the extraordinary medical research endeavours Hudson Research and commercialization by Cleo Diagnostics.
World-class research into womens health happening right here in our home town.”
Source:Hon. Jill Hennessy/LinkedIn